Tnuki vs Zymewire

For most life sciences service sellers: yes. Zymewire's core job is tracking clinical-trial sponsor activity so you know who to call. Tnuki reads that same trial signal — and more — across 40+ integrated databases (ClinicalTrials.gov, NIH RePORTER, openFDA/FAERS, SEC EDGAR, PubMed, Semantic Scholar, plus genomics and regulatory sources), then turns the answer into ranked accounts with the verified buyer and a draft ready to send. If Zymewire's community and its CRO/CDMO-tuned alerts are central to your team's habit, keep them; for the research and the outreach, Tnuki does both in one chat.

An alert feed tells you something happened and leaves the research and outreach to you. Tnuki queries the primary public sources directly and returns exact, checkable numbers, then acts on them. A few real examples (as of June 2026): 38 recruiting trials for the KRAS G12C biomarker and 9 for the EGFR L858R mutation on ClinicalTrials.gov; 31,119 FDA FAERS adverse-event reports for osimertinib, broken down by reaction; 1,169 NIH-funded NSCLC research projects with PI names and dollar amounts from NIH RePORTER; and 2,171 clinical-stage 424B5 offerings on file with the SEC. Every figure links to its public source — and every answer ships with the ranked account, the verified buyer, and a draft.

Yes, and it goes further. Tnuki reads ClinicalTrials.gov directly — including structured search by biomarker, mutation, phase, and status — so you can ask for exactly the trials that matter (e.g. sponsors that started a Phase I this quarter, or trials requiring a specific molecular test). Beyond trials, it also reads NIH grants, FDA FAERS safety data, SEC EDGAR financing filings, and the literature, so a single question spans signals a trial-only feed doesn't carry.

Yes — that outsourcing question is a core CRO and CDMO use case. Ask Tnuki in plain English (e.g. "Which mid-size biotechs just started a Phase I but have no in-house clinical operations team?") and it combines the trial signal from ClinicalTrials.gov with headcount and financing context to rank the sponsors most likely to need an outside partner — then gives you the verified contact and a draft. It's the same job Zymewire's sponsor tracking is built for, done as a synthesized answer instead of an alert you interpret yourself.

It covers that job and more. Zymewire sits in the healthcare commercial intelligence category — tracking life science companies and their trial activity for service sellers. Tnuki does that (trials, sponsors, outsourcing signals) and extends it across NIH grants, FDA FAERS safety data, SEC EDGAR financing, and the scientific literature, then turns any of it into ranked accounts with a verified buyer and a ready draft — so it works for instrument, reagent, diagnostics, software, and financing sellers, not just CRO/CDMO services.

Not natively yet — current options are CSV export and Zapier. Native CRM sync is on the 2026 roadmap.

Some teams keep Zymewire for its CRO/CDMO community and its trial-sponsor alerts, and use Tnuki for everything else — the broader research and the daily outreach motion. Most teams find Tnuki replaces both jobs, since the trial coverage is as deep, the source set is wider, and the output is a sendable draft. Try Tnuki for two weeks alongside Zymewire and see whether you still reach for it.

Tnuki retrieves only public information (LinkedIn, company sites, news, regulatory filings, press releases) via licensed APIs. No scraped private data, no purchased lists. Contact verification happens through GDPR-compliant providers.

Three reasons: (1) Tnuki doesn't stop at the alert — every answer ships with ranked accounts, a verified scientific buyer, and a draft grounded in the trigger; (2) it reads far more than trial activity — NIH grants, FDA FAERS safety data, SEC EDGAR financing, and the literature, all in one chat with exact, verifiable numbers; (3) it's free with no demo or annual contract, where Zymewire is sales-led.